Clinical Trial

A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be implanted into the brain of study participants during a surgical procedure.
Protocol Amendment History 1 change
critical Enrollment closed, study ongoing 2026-07-28
Trial Details
NCT Number NCT07106021
Lead Sponsor Kenai Therapeutics
Collaborators: California Institute for Regenerative Medicine (CIRM)
Conditions Idiopathic Parkinson´s Disease, Parkinson's Disease
Enrollment 12 participants
Start Date 2025-07-17
Primary Completion 2027-09 (estimated)
Study Completion 2031-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-27